Fate Therapeutics (FATE) Shares Issued (2012 - 2015)
Fate Therapeutics' (FATE) quarterly Shares Issued came in at $2.6 million in Q4 2015, up 6.66% YoY from $2.4 million in Q4 2014, and up 2039.24% on a QoQ basis from $120953.0 in Q3 2015.
Fate Therapeutics (FATE) Shares Issued (2012 - 2015) Analysis & Trends
Fate Therapeutics (FATE) has 4 years of Shares Issued data on file, last reported at $2.6 million in Q4 2015.
- Quarterly Shares Issued rose 6.66% year-over-year to $2.6 million in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $2.6 million (up 6.66% YoY) and the FY2015 annual result came in at $2.6 million, up 6.66% from the prior year.
- Shares Issued grew to $2.6 million in Q4 2015, from $120953.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $2.6 million in Q4 2015 to a low of $120953.0 in Q2 2015.
- A 4-year average of $709826.4 and a median of $161689.0 in 2014 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2013 — Shares Issued slumped 87.8% — and 2014, when it soared 1288.41%.
- Tracing FATE's Shares Issued over 4 years: stood at $1.4 million in 2012, then tumbled by 87.8% to $174730.0 in 2013, then soared by 1288.41% to $2.4 million in 2014, then rose by 6.66% to $2.6 million in 2015.
- The last three Shares Issued figures came in at $2.6 million (Q4 2015), $120953.0 (Q3 2015), and $120953.0 (Q2 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Fate Therapeutics | 298.82 Mn | 298.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 2.59 Mn |
| Dec 31, 2015 | 2.59 Mn |
| Sep 30, 2015 | 120,953.00 |
| Sep 30, 2015 | 120,953.00 |
| Jun 30, 2015 | 120,953.00 |
| Jun 30, 2015 | 120,953.00 |
| Mar 31, 2015 | 122,780.00 |
| Mar 31, 2015 | 122,780.00 |
| Dec 31, 2014 | 2.43 Mn |
| Dec 31, 2014 | 2.43 Mn |
| Sep 30, 2014 | 160,526.00 |
| Sep 30, 2014 | 160,526.00 |
| Jun 30, 2014 | 160,526.00 |
| Jun 30, 2014 | 160,526.00 |
| Mar 31, 2014 | 161,689.00 |
| Mar 31, 2014 | 161,689.00 |
| Dec 31, 2013 | 174,730.00 |
| Dec 31, 2013 | 174,730.00 |
| Sep 30, 2013 | 340,121.00 |
| Sep 30, 2013 | 340,121.00 |